A privately held biopharmaceutical company based in the United States. Its development and planned commercialization ...

Exploring clinical development plan options including a controlled human infection model (CHIM) and a Phase 2/3 adaptive ...

Updated versions of best-selling drugs may mitigate some of the impact of patent cliff losses, but the strategy behind the ...

Novo Nordisk should remain one of the leaders in the fast-growing weight loss market, and the company's shares are trading at ...

Let’s find out if it is a good time to buy the stock before the year ends. Valued at $4.2 billion, Viking Therapeutics is a ...

The closest “natural substitute” that aligns with medical advice is to consume a combination of high-fiber foods, lean ...